Last €0.19 EUR
Change Today 0.00 / 0.00%
Volume 0.0
OXX1 On Other Exchanges
Symbol
Exchange
OTC US
Berlin
As of 4:00 PM 02/3/14 All times are local (Market data is delayed by at least 15 minutes).

uluru inc (OXX1) Snapshot

Open
--
Previous Close
€0.19
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
24.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ULURU INC (OXX1)

Related News

No related news articles were found.

uluru inc (OXX1) Related Businessweek News

No Related Businessweek News Found

uluru inc (OXX1) Details

ULURU Inc., a specialty pharmaceutical company, is engaged in the research, development, and commercialization of wound care and mucoadhesive film products in the United States and internationally. The company develops its products based on patented Nanoflex and OraDisc drug delivery technologies. Its products include Altrazeal, a transforming powder dressing for the treatment of various wounds, such as partial thickness burns, donor sites, and abrasions, as well as non-healing surgical, trauma, and chronic wounds, including diabetic foot ulcers, venous leg ulcers, and pressure ulcers; Aphthasol for the treatment of canker sores; OraDisc A for the treatment of oral conditions, which rely upon the use of medications formulated as gels and pastes that are applied to lesions in the mouth; and OraDisc B, a mucoadhesive disc product for the treatment and management of oral pain. The company’s OraDisc products are also used for various dental applications. ULURU Inc. is headquartered in Addison, Texas.

7 Employees
Last Reported Date: 03/31/14

uluru inc (OXX1) Top Compensated Officers

Chairman, Chief Executive Officer, President ...
Total Annual Compensation: $210.0K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $200.0K
Vice President of Polymer Drug Delivery
Total Annual Compensation: $175.0K
Compensation as of Fiscal Year 2013.

uluru inc (OXX1) Key Developments

ULURU Inc. Reports Un-Audited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2014

ULURU Inc. reported un-audited consolidated earnings results for the second quarter and six months ended June 30, 2014. For the quarter, the company reported net loss allocable to common stockholders of $709,715, or $0.03 per basic and diluted common share, as compared with a net loss of $822,785, or $0.06 per basic and diluted common share, for the same period last year. Revenues were $209, 294, as compared to $28,884 for the second quarter of 2013. The increase of approximately $180,000 in revenues is attributable to an increase in total revenue from Altrazeal, including product sales, royalties and license fees. The company reported operating loss of $677,512 compared to $716,048 and loss before income taxes of $709,715 compared to $822,785 for the last year. For the six, the reported net loss allocable to common stockholders of $1.40 million, or $0.06 per basic and diluted common share, as compared with $1.50 million, or $0.12 per basic and diluted common share, for the same period last year. Revenues were $311, 275, as compared to $130,928 for the comparative period of 2013. The increase of approximately $180,000 in revenues is attributable to an increase in total revenue from Altrazeal, including product sales, royalties and license fees. The company reported operating loss of $1,450,957 compared to $1,263,417 and loss before income taxes of $1,401,175 compared to $1,479,375 for the last year.

ULURU Inc., Q2 2014 Earnings Call, Aug 15, 2014

ULURU Inc., Q2 2014 Earnings Call, Aug 15, 2014

ULURU Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2014

ULURU Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2014. For the period, the company’s net loss allocable to common share holders was $691,460 or $0.03 per basic and diluted share compared with a net loss of $668,611 or $0.06 per and diluted share for the same period last year. Revenues for the first quarter of 2014 were $101,980, equivalent to the first quarter of 2013. Operating loss was $773,445 against $547,369 a year ago. Loss before income tax was $691,460 against $656,590 a year ago.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OXX1:GR €0.19 EUR 0.00

OXX1 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
3M Co $144.48 USD +0.54
Smith & Nephew PLC 1,080 GBp +5.00
View Industry Companies
 

Industry Analysis

OXX1

Industry Average

Valuation OXX1 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 51.7x
Price/Book 9.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 51.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ULURU INC, please visit www.uluruinc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.